Developer docs
API playgroundTry for free, no card

Search company profiles

PMG Research

Full company profile

uuid000bvp6

Namestring
PMG Research
Legal namestring
Accellacare Limited
Company typeenum
Private
Founded yearint
1979
Descriptiontext

PMG Research, Inc. is a US-based integrated network of clinical research sites founded in 1979 and headquartered in Winston-Salem, North Carolina. The company operates from approximately 12 metropolitan areas across the United States, providing clinical trial site services to pharmaceutical and biotechnology sponsors. Following integration into the Accellacare Clinical Research network under ICON plc (NYSE: ICLR), the company runs clinical research through both directly operated sites and embedded partnerships with established healthcare providers — including McFarland Clinic (Iowa), Duly Health & Care (Illinois), Piedmont HealthCare (North Carolina), Summit Health, and Asclepes (Florida). Its site footprint spans North Carolina, South Carolina, Tennessee, Iowa, Illinois, California, and Florida.

The company's core offering is a clinical trial enrollment and patient recruitment platform that matches individuals with research studies based on medical conditions and general medical history. Supporting programs include The Patient Voice patient feedback initiative, Lunch and Learn community outreach events, and a Tell-a-Friend referral program offering gift card incentives. The platform integrates with ICON plc's broader clinical trial management infrastructure, providing access to global sponsor relationships and a GDPR-compliant, TrustArc-certified data protection framework. Active studies span therapeutic areas including vaccines (COVID-19, C.Diff, RSV, influenza), oncology, dermatology, neurology (migraine, multiple sclerosis, ADHD), cardiology, endocrinology (diabetes, thyroid disease), respiratory disease, and pediatric indications.

PMG Research generates revenue through contractual agreements with pharmaceutical and biotech sponsors conducting clinical trials, operating on a professional services model. Its customer base includes major pharmaceutical sponsors such as AstraZeneca (Baxduo Pacific study for CKD) and Pfizer (RSV vaccine research), alongside healthcare provider partners that supply patient referrals and clinical infrastructure. The company employs 51-100 staff and operates as a private subsidiary within the publicly traded ICON plc group, distributing its services through direct site operations, healthcare provider partnerships, and multi-channel patient recruitment including digital, social, email, community events, and referral programs.

Short descriptiontext

PMG Research is a US-based integrated network of clinical research sites operating from 12 metropolitan areas, conducting pharmaceutical and biotech-sponsored trials across multiple therapeutic areas under ICON plc's Accellacare network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWinston Salem, United States
HQ citystring
Winston Salem
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices20 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, clinical trial management, patient recruitment, clinical study sites, contract research organization
Industry2 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services
TypeProfessional Services
Description

Accellacare conducts clinical trials on behalf of pharmaceutical and biotech companies. Revenue is generated through contractual agreements with drug developers who need patient populations for clinical research studies. The company operates clinical research sites where trial participants receive investigational medications and study-related care at no cost.

accellacare.us
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PMG Research operates an integrated network of clinical research sites in 12 US metropolitan areas, running clinical trials on behalf of pharmaceutical and biotechnology sponsors. The organization recruits and enrolls patients into studies across therapeutic areas including vaccines, diabetes, cardiovascular disease, respiratory illnesses, neurology, dermatology, oncology, and pediatric conditions, providing study-related care, investigational medications, and financial compensation for time and travel at no cost to participants.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Accellacare Clinical Research, part of ICON plc, operates a clinical trial enrollment platform that connects patients with research studies. The core platform enables registration and matching of individuals with clinical trials based on their medical conditions. The company offers studies across numerous therapeutic areas including vaccines, diabetes, cardiovascular, respiratory, neurology, dermatology, gastroenterology, rheumatology, oncology, and pediatric conditions. Supporting programs include The Patient Voice program for patient feedback, Lunch and Learn community events, and a referral program offering financial incentives.

Product and service5 records
1Accellacare Clinical Trial Enrollment Platform
CategoryClinical trial enrollment platform
2The Patient Voice Program
CategoryPatient engagement program
3Clinical Trial Categories (Therapeutic Area Studies)
CategoryClinical research study services
4Lunch and Learn with Friends
CategoryCommunity outreach program
5Tell a Friend Referral Program
CategoryPatient referral program
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Accellacare is part of ICON plc, one of the world's largest clinical research organizations. ICON plc is responsible for personal data processing including health, race, and ethnicity data. Accellacare operates as a subsidiary under ICON plc's privacy notices and data protection framework.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

McFarland Clinic serves as a clinical research site for Accellacare in Ames, Iowa. They conduct multiple therapeutic area studies including oncology, dermatology, asthma, COPD, obesity, diabetes, and vaccine research.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Duly Health & Care partners with Accellacare as a clinical research site in Chicago, Illinois. They conduct studies across multiple therapeutic areas including CNS, dermatology, infectious disease, respiratory, oncology, and diabetes.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Piedmont HealthCare serves as a clinical research site for Accellacare in Statesville, North Carolina. They conduct studies across multiple therapeutic areas.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Summit Health partners with Accellacare to conduct clinical trials across multiple therapeutic areas including weight management, heart health, migraine, and constipation research.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Asclepes operates as a clinical research site partner with Accellacare in Florida locations including Brooksville, Lutz, and Spring Hill.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

AstraZeneca partners with Accellacare for clinical trials including the Baxduo Pacific study for Chronic Kidney Disease & High Blood Pressure research.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Pfizer partners with Accellacare for RSV vaccine research studies targeting adults 65 years and older.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Lightship partners with Accellacare for patient recruitment outreach campaigns, particularly for diabetes and vaccine research studies.

Strategic tierMinorTypeGTM or Marketing Partner
Description

National Kidney Foundation partners with Accellacare and AstraZeneca for the Chronic Kidney Disease & High Blood Pressure Research Study.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest US dedicated site-management organizations operating a multi-therapeutic clinical research site network. Directly comparable to PMG/Accellacare as a multi-state SMO serving pharma/biotech sponsors across similar therapeutic areas.

TypeDirect peer
Description

US-based integrated clinical research site network formed through roll-ups, operating multiple sites across multiple therapeutic areas. Directly comparable in business model (multi-site SMO) and customer base (pharma/biotech sponsors).

TypeDirect peer
Description

US clinical research site network that recruits and conducts trials for pharma sponsors. Comparable as a multi-site SMO with patient-recruitment focus, though smaller in scale than PMG/Accellacare.

TypeDirect peer
Description

US-based integrated clinical research site organization operating across multiple therapeutic areas. Direct peer in the multi-site SMO category serving similar pharma/biotech sponsors.

TypeDirect peer
Description

Multi-site US clinical research organization conducting trials in vaccines, infectious disease, and general medicine. Directly comparable as a regional-to-multi-regional SMO serving enterprise sponsors.

TypeBroad incumbent
Description

One of the world's largest CROs with significant site-management capabilities alongside its broader clinical and commercial services portfolio. Comparable as a parent-of-peer and broad competitor in clinical trial site services.

TypeBroad incumbent
Description

Large global CRO with site-management offerings as part of its full-service clinical development portfolio. Comparable as a broader incumbent competing for the same sponsor relationships and protocols.

TypeBroad incumbent
Description

Mid-to-large global CRO with strong site-management infrastructure and a focus on full-service clinical development. Comparable as a broader incumbent in the CRO/site-services category serving similar sponsors.

TypeBroad incumbent
Description

Global clinical research services provider (now part of Thermo Fisher) operating across CRO and site-services. Comparable as a broad incumbent competing for sponsor study placements.

TypeOthers
Description

Patient logistics and concierge services provider supporting clinical trial participants and sites. Adjacent enabling participant in the clinical-trial ecosystem serving similar sponsors and patient populations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PMG Research

Clinical Research Servicespmg-research.com

PMG Research is a US-based integrated network of clinical research sites operating from 12 metropolitan areas, conducting pharmaceutical and biotech-sponsored trials across multiple therapeutic areas under ICON plc's Accellacare network.

What PMG Research does

PMG Research, Inc. is a US-based integrated network of clinical research sites founded in 1979 and headquartered in Winston-Salem, North Carolina. The company operates from approximately 12 metropolitan areas across the United States, providing clinical trial site services to pharmaceutical and biotechnology sponsors. Following integration into the Accellacare Clinical Research network under ICON plc (NYSE: ICLR), the company runs clinical research through both directly operated sites and embedded partnerships with established healthcare providers — including McFarland Clinic (Iowa), Duly Health & Care (Illinois), Piedmont HealthCare (North Carolina), Summit Health, and Asclepes (Florida). Its site footprint spans North Carolina, South Carolina, Tennessee, Iowa, Illinois, California, and Florida.

The company's core offering is a clinical trial enrollment and patient recruitment platform that matches individuals with research studies based on medical conditions and general medical history. Supporting programs include The Patient Voice patient feedback initiative, Lunch and Learn community outreach events, and a Tell-a-Friend referral program offering gift card incentives. The platform integrates with ICON plc's broader clinical trial management infrastructure, providing access to global sponsor relationships and a GDPR-compliant, TrustArc-certified data protection framework. Active studies span therapeutic areas including vaccines (COVID-19, C.Diff, RSV, influenza), oncology, dermatology, neurology (migraine, multiple sclerosis, ADHD), cardiology, endocrinology (diabetes, thyroid disease), respiratory disease, and pediatric indications.

PMG Research generates revenue through contractual agreements with pharmaceutical and biotech sponsors conducting clinical trials, operating on a professional services model. Its customer base includes major pharmaceutical sponsors such as AstraZeneca (Baxduo Pacific study for CKD) and Pfizer (RSV vaccine research), alongside healthcare provider partners that supply patient referrals and clinical infrastructure. The company employs 51-100 staff and operates as a private subsidiary within the publicly traded ICON plc group, distributing its services through direct site operations, healthcare provider partnerships, and multi-channel patient recruitment including digital, social, email, community events, and referral programs.

PMG Research firmographics

Firmographics
Name
PMG Research
Legal name
Accellacare Limited
Website
https://pmg-research.com
Company type
Private
Founded year
1979
Operating status
Operating
Headcount range
51–100 employees
Short description
PMG Research is a US-based integrated network of clinical research sites operating from 12 metropolitan areas, conducting pharmaceutical and biotech-sponsored trials across multiple therapeutic areas under ICON plc's Accellacare network.
Ownership category
akta.pro rank

PMG Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAG
Clinical Trial Monitoring Support (On-site/Remote)

Keywords

  • Clinical research services
  • Clinical trial management
  • Patient recruitment
  • Clinical study sites
  • Contract research organization

Where PMG Research is headquartered

Location

Headquarters

HQ city
Winston Salem
HQ country
United States
HQ region
North America

Offices20 records

Markets served

PMG Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Services: Accellacare conducts clinical trials on behalf of pharmaceutical and biotech companies. Revenue is generated through contractual agreements with drug developers who need patient populations for clinical research studies. The company operates clinical research sites where trial participants receive investigational medications and study-related care at no cost.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

PMG Research product offering

Product offering

Core offering

PMG Research operates an integrated network of clinical research sites in 12 US metropolitan areas, running clinical trials on behalf of pharmaceutical and biotechnology sponsors. The organization recruits and enrolls patients into studies across therapeutic areas including vaccines, diabetes, cardiovascular disease, respiratory illnesses, neurology, dermatology, oncology, and pediatric conditions, providing study-related care, investigational medications, and financial compensation for time and travel at no cost to participants.

Product overview

Accellacare Clinical Research, part of ICON plc, operates a clinical trial enrollment platform that connects patients with research studies. The core platform enables registration and matching of individuals with clinical trials based on their medical conditions. The company offers studies across numerous therapeutic areas including vaccines, diabetes, cardiovascular, respiratory, neurology, dermatology, gastroenterology, rheumatology, oncology, and pediatric conditions. Supporting programs include The Patient Voice program for patient feedback, Lunch and Learn community events, and a referral program offering financial incentives.

Differentiator

Problem solved

Functional benefit

Products and services

  • Accellacare Clinical Trial Enrollment Platform
  • The Patient Voice Program
  • Clinical Trial Categories (Therapeutic Area Studies)
  • Lunch and Learn with Friends
  • Tell a Friend Referral Program

Companies that use PMG Research

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles3 records

PMG Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

PMG Research partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, major and minor.

  • ICON plccoreStrategic or Co-development PartnerAccellacare is part of ICON plc, one of the world's largest clinical research organizations. ICON plc is responsible for personal data processing including health, race, and ethnicity data. Accellacare operates as a subsidiary under ICON plc's privacy notices and data protection framework.
  • McFarland ClinicmajorChannel Partner/ Reseller/ DistributorMcFarland Clinic serves as a clinical research site for Accellacare in Ames, Iowa. They conduct multiple therapeutic area studies including oncology, dermatology, asthma, COPD, obesity, diabetes, and vaccine research.
  • Duly Health & CaremajorChannel Partner/ Reseller/ DistributorDuly Health & Care partners with Accellacare as a clinical research site in Chicago, Illinois. They conduct studies across multiple therapeutic areas including CNS, dermatology, infectious disease, respiratory, oncology, and diabetes.
  • Piedmont HealthCaremajorChannel Partner/ Reseller/ DistributorPiedmont HealthCare serves as a clinical research site for Accellacare in Statesville, North Carolina. They conduct studies across multiple therapeutic areas.
  • Summit HealthmajorChannel Partner/ Reseller/ DistributorSummit Health partners with Accellacare to conduct clinical trials across multiple therapeutic areas including weight management, heart health, migraine, and constipation research.
  • AsclepesminorChannel Partner/ Reseller/ DistributorAsclepes operates as a clinical research site partner with Accellacare in Florida locations including Brooksville, Lutz, and Spring Hill.
  • AstraZenecamajorStrategic or Co-development PartnerAstraZeneca partners with Accellacare for clinical trials including the Baxduo Pacific study for Chronic Kidney Disease & High Blood Pressure research.
  • PfizermajorStrategic or Co-development PartnerPfizer partners with Accellacare for RSV vaccine research studies targeting adults 65 years and older.
  • LightshipminorGTM or Marketing PartnerLightship partners with Accellacare for patient recruitment outreach campaigns, particularly for diabetes and vaccine research studies.
  • National Kidney FoundationminorGTM or Marketing PartnerNational Kidney Foundation partners with Accellacare and AstraZeneca for the Chronic Kidney Disease & High Blood Pressure Research Study.

Scale indicators2 records

Recent moves1 record

Expansion highlights5 records

PMG Research competitors and assessment

Company assessment

Direct peers

  • Velocity Clinical Research: One of the largest US dedicated site-management organizations operating a multi-therapeutic clinical research site network. Directly comparable to PMG/Accellacare as a multi-state SMO serving pharma/biotech sponsors across similar therapeutic areas.
  • Flourish Research: US-based integrated clinical research site network formed through roll-ups, operating multiple sites across multiple therapeutic areas. Directly comparable in business model (multi-site SMO) and customer base (pharma/biotech sponsors).
  • Circuit Clinical: US clinical research site network that recruits and conducts trials for pharma sponsors. Comparable as a multi-site SMO with patient-recruitment focus, though smaller in scale than PMG/Accellacare.
  • DM Clinical Research: US-based integrated clinical research site organization operating across multiple therapeutic areas. Direct peer in the multi-site SMO category serving similar pharma/biotech sponsors.
  • Benchmark Research: Multi-site US clinical research organization conducting trials in vaccines, infectious disease, and general medicine. Directly comparable as a regional-to-multi-regional SMO serving enterprise sponsors.

Broad incumbents

  • IQVIA: One of the world's largest CROs with significant site-management capabilities alongside its broader clinical and commercial services portfolio. Comparable as a parent-of-peer and broad competitor in clinical trial site services.
  • Syneos Health: Large global CRO with site-management offerings as part of its full-service clinical development portfolio. Comparable as a broader incumbent competing for the same sponsor relationships and protocols.
  • Medpace: Mid-to-large global CRO with strong site-management infrastructure and a focus on full-service clinical development. Comparable as a broader incumbent in the CRO/site-services category serving similar sponsors.
  • PPD (Thermo Fisher Scientific): Global clinical research services provider (now part of Thermo Fisher) operating across CRO and site-services. Comparable as a broad incumbent competing for sponsor study placements.

Others

  • Clincierge: Patient logistics and concierge services provider supporting clinical trial participants and sites. Adjacent enabling participant in the clinical-trial ecosystem serving similar sponsors and patient populations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

PMG Research social profiles

Digital presence

PMG Research compliance and trust

Trust signal

Compliance2 records

PMG Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PMG Research leadership team

Management profile

Number of profiles

Profiles1 record

PMG Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PMG Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PMG Research

What does PMG Research do?

PMG Research operates an integrated network of clinical research sites in 12 US metropolitan areas, running clinical trials on behalf of pharmaceutical and biotechnology sponsors. The organization recruits and enrolls patients into studies across therapeutic areas including vaccines, diabetes, cardiovascular disease, respiratory illnesses, neurology, dermatology, oncology, and pediatric conditions, providing study-related care, investigational medications, and financial compensation for time and travel at no cost to participants.

Is PMG Research a public or private company?

PMG Research is a private company. It is classified as corporate owned and is currently operating.

When was PMG Research founded?

PMG Research was founded in 1979. It employs 51 to 100 people.

Where is PMG Research based?

PMG Research is headquartered in Winston Salem, United States, in the North America region.

How does PMG Research make money?

One revenue line is on record: clinical Trial Services.

Who are PMG Research's main competitors?

Direct peers on record are Velocity Clinical Research, Flourish Research, Circuit Clinical, DM Clinical Research and Benchmark Research. Broad incumbents are IQVIA, Syneos Health, Medpace and PPD (Thermo Fisher Scientific). Clincierge is listed as an others.

Does PMG Research have an API?

No public API is recorded for PMG Research.

What industry is PMG Research in?

PMG Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogICON Launches Accellacare a Global Clinical Research Network Focused on Increasing Patient Recruitment With a Patient Centric ApproachICON launched Accellacare, a global clinical research network for patient recruitment in decentralised trials, integrating acquired PMG Research and MeDiNova Research. The network operates 77 active sites across seven countries, connecting to 8 million+ patients, and aims to improve recruitment and retention.ICON plcMotivating Patients to Participate in Multiple Clinical TrialsSeven patients from PMG Research were interviewed about their motivations for participating in multiple clinical trials. Most cited dissatisfaction with current treatment as the primary driver, and only two were approached by a physician. The study plans to expand to a larger population in Q3 2018 to validate the findings.News-MedicalICON and DuPage Medical Group announce clinical research partnershipICON and DuPage Medical Group finalized a clinical research partnership, with PMG Research assuming DuPage's infrastructure effective May 2018. The expansion adds investigator and patient access in the greater Chicago area, aiming to reduce drug development time and cost.PR NewswirePMG Research Partners With Devana Solutions To Accelerate Growth Of Business & MissionPMG Research, Inc. and Devana Solutions, LLC announced a long-term subscription agreement for Devana's Ignite for Sites cloud-based platform across PMG's network of over 50 investigative site locations. The technology will automate PMG's clinical trial operations from study lead through trial completion, enabling real-time tracking and reporting of timing and performance metrics across its entire site network. PMG, which has completed over 7,700 clinical trials across 14 hub sites in the US, stated the partnership will help demonstrate its performance credentials to pharmaceutical sponsors and CROs while expanding its industry position.